Real-time enrollment status for this liver cancer (fibrolamellar hepatocellular cancer (flc)) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 5:53 PM UTC
| NCT Number | NCT07430202 |
| Recruiting Status | Recruiting |
| Condition | Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) |
| Phase | PHASE1 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07430202 is currently recruiting participants. This phase1 study for liver cancer (fibrolamellar hepatocellular cancer (flc)) is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07430202 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07430202 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.